2. Academic Validation
  3. Knocking Down CDKN2A Enhances the Therapeutic Effects of Metformin and Resveratrol on Diabetic Retinopathy

Knocking Down CDKN2A Enhances the Therapeutic Effects of Metformin and Resveratrol on Diabetic Retinopathy

  • Appl Biochem Biotechnol. 2026 Jun;198(6):4353-4375. doi: 10.1007/s12010-026-05664-3.
Jinghua Li # 1,  Junyi Liu # 1,  Jiang Li 2,  Yongying Tang 1,  Zailin Xiao 3,  Yan Xu 1,  Xueying Zhao 4
Affiliations

Affiliations

  • 1 Ophthalmology Department, The Second Affiliated Hospital of Kunming Medical University, Kunming, 650000, China.
  • 2 Ophthalmology Department, Kunming Children's Hospital, Kunming, 650100, China.
  • 3 Ophthalmology Department, Qujing Aier Eye Hospital, 655000, Qujing, China.
  • 4 Ophthalmology Department, The Second Affiliated Hospital of Kunming Medical University, Kunming, 650000, China. [email protected].
  • # Contributed equally.
PMID: 41843007 DOI: 10.1007/s12010-026-05664-3
Keywords

CDKN2A; Diabetic retinopathy; METTL3; Mitochondrial function; m6A Methylation.

Figures
Products